SK284542B6 - Prípadne substituované 8-kyán-1-cyklopropyl-7-(2,8-diazabicyklo- [4,3,0]-nonán-8-yl)-6-fluór-1,4-dihydro-4-oxo-3- chinolínkarboxylové kyseliny a ich deriváty, spôsob ich výroby a ich použitie ako liečiv - Google Patents

Prípadne substituované 8-kyán-1-cyklopropyl-7-(2,8-diazabicyklo- [4,3,0]-nonán-8-yl)-6-fluór-1,4-dihydro-4-oxo-3- chinolínkarboxylové kyseliny a ich deriváty, spôsob ich výroby a ich použitie ako liečiv Download PDF

Info

Publication number
SK284542B6
SK284542B6 SK1146-98A SK114698A SK284542B6 SK 284542 B6 SK284542 B6 SK 284542B6 SK 114698 A SK114698 A SK 114698A SK 284542 B6 SK284542 B6 SK 284542B6
Authority
SK
Slovakia
Prior art keywords
methyl
oxo
group
cyano
diazabicyclo
Prior art date
Application number
SK1146-98A
Other languages
English (en)
Slovak (sk)
Other versions
SK114698A3 (en
Inventor
Stefan Bartel
Thomas Jaetsch
Thomas Himmler
Hans-Georg Rast
Werner Hallenbach
Ernst Heinen
Franz Pirro
Martin Scheer
Michael Stegemann
Hans-Peter Stupp
Heinz-Georg Wetzstein
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19633805A external-priority patent/DE19633805A1/de
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of SK114698A3 publication Critical patent/SK114698A3/sk
Publication of SK284542B6 publication Critical patent/SK284542B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Plant Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SK1146-98A 1996-02-23 1997-02-12 Prípadne substituované 8-kyán-1-cyklopropyl-7-(2,8-diazabicyklo- [4,3,0]-nonán-8-yl)-6-fluór-1,4-dihydro-4-oxo-3- chinolínkarboxylové kyseliny a ich deriváty, spôsob ich výroby a ich použitie ako liečiv SK284542B6 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19606762 1996-02-23
DE19633805A DE19633805A1 (de) 1996-02-23 1996-08-22 Gegenenenfalls substituierte 8-Cyan-l-cyclopropyl-7-(2,8-diazabicyclo-[4.3.0]-nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäuren und ihre Derivate
PCT/EP1997/000637 WO1997031001A1 (de) 1996-02-23 1997-02-12 Gegebenenfalls substituierte 8-cyan-1-cyclopropyl-7-(2,8-diazabicyclo-[4.3.0]-nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäuren und ihre derivate

Publications (2)

Publication Number Publication Date
SK114698A3 SK114698A3 (en) 1999-01-11
SK284542B6 true SK284542B6 (sk) 2005-06-02

Family

ID=26023165

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1146-98A SK284542B6 (sk) 1996-02-23 1997-02-12 Prípadne substituované 8-kyán-1-cyklopropyl-7-(2,8-diazabicyklo- [4,3,0]-nonán-8-yl)-6-fluór-1,4-dihydro-4-oxo-3- chinolínkarboxylové kyseliny a ich deriváty, spôsob ich výroby a ich použitie ako liečiv

Country Status (23)

Country Link
US (2) US6323213B1 (no)
EP (1) EP0882049B1 (no)
JP (1) JP4338217B2 (no)
CN (2) CN1073112C (no)
AT (1) ATE228130T1 (no)
AU (1) AU715341B2 (no)
BR (1) BR9707606B1 (no)
CA (1) CA2247020C (no)
CZ (1) CZ291251B6 (no)
DE (1) DE59708771D1 (no)
DK (1) DK0882049T3 (no)
ES (1) ES2184060T3 (no)
HK (1) HK1018903A1 (no)
HU (1) HU228036B1 (no)
IL (1) IL125444A (no)
NO (2) NO311521B1 (no)
NZ (1) NZ331468A (no)
PL (1) PL186737B1 (no)
PT (1) PT882049E (no)
RU (1) RU2173318C2 (no)
SK (1) SK284542B6 (no)
TR (1) TR199801493T2 (no)
WO (1) WO1997031001A1 (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19717231A1 (de) * 1997-04-24 1998-10-29 Bayer Ag 3-Cyano-2,4,5-trifluor-benzoylfluorid
DE19733243A1 (de) * 1997-08-01 1999-02-04 Bayer Ag Verfahren zur Herstellung von 3-Cyano-2,4-dihalogen-5-fluor-benzoesäure
DE19826050A1 (de) * 1998-06-12 1999-12-16 Bayer Ag Verfahren zur Herstellung von Chinolon- und Naphthyridoncarbonsäuren und deren Ester
DE19854356A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation A von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854357A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19908448A1 (de) * 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation D von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo[4.3.0)nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino incarbonsäure
DE19908449A1 (de) * 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation C von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino/incarbonsäure
DE10224086A1 (de) * 2002-05-31 2003-12-11 Bayer Ag Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker
DE10312346A1 (de) * 2003-03-20 2004-09-30 Bayer Healthcare Ag Kontrolliertes Freisetzungssystem
DE10337191A1 (de) * 2003-08-13 2005-03-17 Bayer Healthcare Ag Neue Verwendung von Chinolon-Antibiotika
WO2005030752A1 (ja) 2003-09-29 2005-04-07 Daiichi Pharmaceutical Co., Ltd. ８−シアノキノロンカルボン酸誘導体
DE10351448A1 (de) 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
DE102004015981A1 (de) * 2004-04-01 2005-10-20 Bayer Healthcare Ag Neue kirstalline Form von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
CN1244582C (zh) * 2004-04-21 2006-03-08 中国医学科学院医药生物技术研究所 喹诺酮羧酸类化合物及其制备方法和医药用途
US7759362B2 (en) * 2004-04-21 2010-07-20 Institut Of Medicinal Biotechnology Chinese Academy Of Medical Sciences Quinolonecarboxylic acid compounds, preparation methods and pharmaceutical uses thereof
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
DE102006010643A1 (de) * 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Arzneimittel enthaltend Fluorchinolone
DE102006049520A1 (de) 2006-10-20 2008-04-24 Bayer Healthcare Ag Verfahren zur Herstellung von Pradofloxacin
WO2008059521A2 (en) * 2006-11-14 2008-05-22 Msn Laboratories Limited Novel process for the preparation of moxifloxacin hydrochloride and a novel polymorph of moxifloxacin
CN101020658B (zh) * 2007-02-14 2010-12-15 杭州师范学院 喹诺酮主环化合物的合成方法
DE102007026550A1 (de) 2007-06-08 2008-12-11 Bayer Healthcare Ag Extrudate mit verbesserter Geschmacksmaskierung
DE102007055341A1 (de) 2007-11-19 2009-05-20 Bayer Animal Health Gmbh Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren
EP2429991B1 (en) 2009-05-15 2014-09-10 Redx Pharma Limited Redox drug derivatives
CN102603531B (zh) * 2012-02-22 2014-04-02 仙居县力天化工有限公司 一种串联法制备2,3,4,5-四氟苯甲酸甲酯的方法
JP6228975B2 (ja) * 2012-07-13 2017-11-08 ソルヴェイ（ソシエテ アノニム） 三重結合を有するフッ化カルボニル化合物、その製造方法、及びその使用
JP7257322B2 (ja) 2017-02-13 2023-04-13 バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング プラドフロキサシンを含有する液体組成物
CN107987074B (zh) * 2017-10-27 2020-12-29 浙江美诺华药物化学有限公司 一种普拉沙星的合成方法
CA3098060A1 (en) 2018-04-25 2019-10-31 Bayer Animal Health Gmbh Process for the hydrolysis of quinolone carboxylic esters
CN112881542B (zh) * 2020-10-28 2022-11-18 上海安谱实验科技股份有限公司 一种稳定同位素氘标记的达氟沙星及其合成方法
CN114716373B (zh) * 2022-04-14 2023-01-10 内蒙古源宏精细化工有限公司 一种加替沙星环合酯的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
DE3910663A1 (de) * 1989-04-03 1990-10-04 Bayer Ag 5-alkylchinoloncarbonsaeuren
US5140033A (en) 1989-04-03 1992-08-18 Bayer Aktiengesellschaft Antibacterial 5-alkylquinolonecarboxylic acids
US5252734A (en) * 1989-04-03 1993-10-12 Bayer Aktiengesellschaft Antibacterial 5-alkylquinolonecarboxylic acids
NO301165B1 (no) * 1992-12-25 1997-09-22 Daiichi Seiyaku Co Bicykliske aminderivater og antibakterielle midler inneholdende disse

Also Published As

Publication number Publication date
WO1997031001A1 (de) 1997-08-28
CA2247020A1 (en) 1997-08-28
NZ331468A (en) 2000-02-28
CA2247020C (en) 2005-11-08
RU2173318C2 (ru) 2001-09-10
EP0882049B1 (de) 2002-11-20
HU228036B1 (en) 2012-08-28
CN1211984A (zh) 1999-03-24
ATE228130T1 (de) 2002-12-15
ES2184060T3 (es) 2003-04-01
JP2000504734A (ja) 2000-04-18
SK114698A3 (en) 1999-01-11
PT882049E (pt) 2003-04-30
PL186737B1 (pl) 2004-02-27
CN1335301A (zh) 2002-02-13
CN1073112C (zh) 2001-10-17
NO2011022I1 (no) 2011-10-17
DK0882049T3 (da) 2003-03-03
US6323213B1 (en) 2001-11-27
CZ268498A3 (cs) 1999-02-17
AU1768997A (en) 1997-09-10
JP4338217B2 (ja) 2009-10-07
NO2011022I2 (no) 2013-02-18
PL328577A1 (en) 1999-02-01
NO311521B1 (no) 2001-12-03
HK1018903A1 (en) 2000-01-07
HUP9900502A3 (en) 2000-02-28
TR199801493T2 (xx) 1998-10-21
CZ291251B6 (cs) 2003-01-15
EP0882049A1 (de) 1998-12-09
IL125444A (en) 2001-03-19
US6278013B1 (en) 2001-08-21
HUP9900502A2 (hu) 1999-06-28
NO983819L (no) 1998-08-20
DE59708771D1 (de) 2003-01-02
IL125444A0 (en) 1999-03-12
BR9707606B1 (pt) 2010-08-10
AU715341B2 (en) 2000-01-20
NO983819D0 (no) 1998-08-20
BR9707606A (pt) 1999-07-27

Similar Documents

Publication Publication Date Title
SK284542B6 (sk) Prípadne substituované 8-kyán-1-cyklopropyl-7-(2,8-diazabicyklo- [4,3,0]-nonán-8-yl)-6-fluór-1,4-dihydro-4-oxo-3- chinolínkarboxylové kyseliny a ich deriváty, spôsob ich výroby a ich použitie ako liečiv
JP3046035B2 (ja) ５―アルキルキノロンカルボン酸類
SK2212000A3 (sk) Enantiomérne čisté deriváty kyseliny chinolónkarboxylovej a naftyridónkarboxylovej, spôsob ich výroby, liečivá tieto látky obsahujúce a ich použitie
JP2002512226A (ja) 置換された２−オキソ−アルカン酸−［２−（インドール−３−イル）−エチル］アミド
KR100493576B1 (ko) 임의로치환된8-시아노-1-사이클로프로필-7-(2,8-디아자비사이클로-[4.3.0]-노난-8-일)-6-플루오로-1,4-디하이드로-4-옥소-3-퀴놀린카르복실산및그의유도체
CS270600B2 (en) Method of new quinoline derivatives production
US5744478A (en) Thiazolo 3,2-a! quinoline and thiazolo 3,2-a! naphthyridine derivatives
AU720322B2 (en) 7-(3-Vinyl-1,4-piperazin-1-yl)-substituted quinolonecarboxylic acids
KR100682746B1 (ko) 항박테리아제로서의n-옥사이드
KR20000016807A (ko) 7-(3-비닐-1,4-피페라진-1-일)에 의해 치환된 퀴놀론카복실산
JPH0873468A (ja) ８−アミノ−１０−（アザビシクロアルキル）−ピリド［１，２，３−ｄ，ｅ］［１，３，４］ベンズオキサジアジン誘導体
KR100332527B1 (ko) 피리돈카르본산유도체또는이것의염및그제조방법
HUT71605A (en) New 8-amino-pyrido[1,2,3-d,e][1,3,4]benzoxadiazine derivatives, process for producing them, and pharmaceutical compositions containing them
JPH0841073A (ja) １，９−架橋チアゾロ［３，２−ａ］キノリン誘導体
DE19651687A1 (de) 7-(3-Vinyl-1,4-piperazin-1-yl)-substituierte Chinoloncarbonsäuren
CS277016B6 (en) Novel derivatives of quinoline, process of their preparation and a pharmaceutical based thereon

Legal Events

Date Code Title Description
SPCF Filing of an spc

Free format text: PRODUCT NAME: PRADOFLOXACIN; REGISTRATION NO/DATE: EU/2/10/107/001 - EU/2/10/107/014 20110412

Spc suppl protection certif: 5012-2011

Filing date: 20111011

SPCG Grant of an spc

Free format text: PRODUCT NAME: PRADOFLOXACIN; REGISTRATION NO/DATE: EU/2/10/107/001 - EU/2/10/107/014 20110412

Spc suppl protection certif: 108 5012-2011

Filing date: 20111011

Extension date: 20220213

PC4A Assignment and transfer of rights

Owner name: BAYER INTELLECTUAL PROPERTY GMBH, MONHEIM AM R, DE

Free format text: FORMER OWNER: BAYER ANIMAL HEALTH GMBH, LEVERKUSEN, DE

Effective date: 20121011

SPCT Transfer of rights of an spc

Owner name: BAYER INTGELLECTUAL PROPERTY GMBH; DE

Free format text: PRODUCT NAME: PRADOFLOXACIN; REGISTRATION NO/DATE: EU/2/10/107/001-014 20110421

Spc suppl protection certif: DO 108; 5012-2011

Filing date: 20111011

Extension date: 20220213

Effective date: 20130108

MK4A Expiry of patent

Expiry date: 20170212